[go: up one dir, main page]

AU2002222610A1 - Transgenic animal expressing hla-a24 and utilization thereof - Google Patents

Transgenic animal expressing hla-a24 and utilization thereof

Info

Publication number
AU2002222610A1
AU2002222610A1 AU2002222610A AU2261002A AU2002222610A1 AU 2002222610 A1 AU2002222610 A1 AU 2002222610A1 AU 2002222610 A AU2002222610 A AU 2002222610A AU 2261002 A AU2261002 A AU 2261002A AU 2002222610 A1 AU2002222610 A1 AU 2002222610A1
Authority
AU
Australia
Prior art keywords
utilization
transgenic animal
expressing hla
animal expressing
hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222610A
Inventor
Masashi Gotoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2002222610A1 publication Critical patent/AU2002222610A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2002222610A 2000-12-13 2001-12-12 Transgenic animal expressing hla-a24 and utilization thereof Abandoned AU2002222610A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-378556 2000-12-13
JP2000378556 2000-12-13
JP2001-269746 2001-09-06
JP2001269746 2001-09-06
PCT/JP2001/010885 WO2002047474A1 (en) 2000-12-13 2001-12-12 Transgenic animal expressing hla-a24 and utilization thereof

Publications (1)

Publication Number Publication Date
AU2002222610A1 true AU2002222610A1 (en) 2002-06-24

Family

ID=26605731

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222610A Abandoned AU2002222610A1 (en) 2000-12-13 2001-12-12 Transgenic animal expressing hla-a24 and utilization thereof

Country Status (4)

Country Link
US (2) US20050050580A1 (en)
JP (1) JPWO2002047474A1 (en)
AU (1) AU2002222610A1 (en)
WO (1) WO2002047474A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2189470A1 (en) * 2001-12-10 2010-05-26 Green Peptide Co., Ltd. Tumor antigens
CA2513701C (en) 2003-01-15 2013-06-18 Haruo Sugiyama Dimerized peptide
EP2343083B1 (en) 2003-06-27 2014-01-15 International Institute of Cancer Immunology, Inc. Method of diagnosing cancer comprising the measurement of WT1-specific CTL precursor cells
PL2071028T3 (en) 2003-11-05 2012-06-29 Int Inst Cancer Immunology Inc HLA-DR-binding antigen peptide derived from WT1
WO2007066423A1 (en) * 2005-12-08 2007-06-14 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen peptide derived from amacr
CN101448938A (en) 2006-03-28 2009-06-03 佐藤升志 Novel tumor antigen peptides
ATE555212T1 (en) * 2007-03-02 2012-05-15 Biosante Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR IDENTIFYING PROSTATE CANCER OR A HUMORAL IMMUNE RESPONSE TO PROSTATE CANCER
JP5606322B2 (en) 2008-10-20 2014-10-15 昇志 佐藤 Tumor antigen peptide and use thereof
SMT202100243T1 (en) * 2011-10-28 2021-05-07 Regeneron Pharma Genetically modified t cell receptor mice
US9591835B2 (en) 2011-10-28 2017-03-14 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
DK2770821T3 (en) * 2011-10-28 2017-11-27 Regeneron Pharma GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MOUSE
KR101926442B1 (en) 2011-10-28 2018-12-12 리제너론 파아마슈티컬스, 인크. Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules
US9043996B2 (en) 2011-10-28 2015-06-02 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
EP2868325B1 (en) 2012-07-02 2017-11-01 Sumitomo Dainippon Pharma Co., Ltd. Transdermal cancer antigen peptide preparation
LT2958938T (en) 2013-02-20 2019-07-25 Regeneron Pharmaceuticals, Inc. MOUSE EXPRESSING HUMANIZED T-CELL CORECEPTORS
US20150342163A1 (en) 2013-02-22 2015-12-03 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex mice
EP2958937B1 (en) 2013-02-22 2018-08-15 Regeneron Pharmaceuticals, Inc. Mice expressing humanized major histocompatibility complex
WO2014164640A1 (en) * 2013-03-11 2014-10-09 Regeneron Pharmaceuticals, Inc. Transgenic mice expressing chimeric major histocompatibility complex (mhc) class i molecules
EP3461493A1 (en) 2013-03-29 2019-04-03 Sumitomo Dainippon Pharma Co., Ltd. Wt1 antigen peptide conjugate vaccine
JP6671956B2 (en) * 2013-03-29 2020-03-25 大日本住友製薬株式会社 Conjugate vaccine triggered by trimming function by ERAP1
US20160166666A1 (en) 2013-07-12 2016-06-16 Sumitomo Dainippon Pharma Co., Ltd. Tumor antigen peptide
JPWO2015050259A1 (en) 2013-10-03 2017-03-09 大日本住友製薬株式会社 Tumor antigen peptide
KR20240132525A (en) 2015-04-06 2024-09-03 리제너론 파아마슈티컬스, 인크. Humanized t cell mediated immune responses in non-human animals
EP3549957A4 (en) 2016-11-30 2020-08-05 Sumitomo Dainippon Pharma Co., Ltd. WT1-HELPER PEPTIDE AND COMBINATION OF THE SAYING PEPTIDE AND A CANCER ANTIGEN PEPTIDE CONJUGATE
US20210100886A1 (en) 2017-03-30 2021-04-08 Sumitomo Dainippon Pharma Co., Ltd. Wt1 cancer antigen peptides and peptide conjugates comprising the peptides
JP7162675B2 (en) 2018-09-28 2022-10-28 住友ファーマ株式会社 Injectable composition
MX2022014249A (en) 2020-05-12 2023-02-22 Sumitomo Pharma Co Ltd PHARMACEUTICAL COMPOSITION TO TREAT CANCER.
CN118511853A (en) 2021-03-31 2024-08-20 瑞泽恩制药公司 Genetically modified mice comprising humanized cellular immune system components with improved TCRB repertoire diversity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1106736A (en) * 1914-02-05 1914-08-11 George Schuler Conveyer.
US2592481A (en) * 1948-06-18 1952-04-08 Arthur M Spencer Fiber beater for the liberation of cellulose fibers
US3326642A (en) * 1964-02-24 1967-06-20 Continental Carbon Co Plastic lined carbon black agglomerator
US3601371A (en) * 1968-11-19 1971-08-24 Abe D Ross Mixer dispenser
US3825233A (en) * 1972-02-14 1974-07-23 Phillips Petroleum Co Carbon black pelleter
US4159181A (en) * 1976-12-23 1979-06-26 American Pelletizing Corporation Mixing and pelletizing machine
US4171165A (en) * 1978-07-17 1979-10-16 Diamond Insulation Industries, Inc. Cellulose insulation storage bin with improved debridger

Also Published As

Publication number Publication date
US20050050580A1 (en) 2005-03-03
JPWO2002047474A1 (en) 2004-04-15
US7339089B2 (en) 2008-03-04
US20060107339A1 (en) 2006-05-18
WO2002047474A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2002222610A1 (en) Transgenic animal expressing hla-a24 and utilization thereof
AU2002366306A1 (en) Animal breeding system and utilization of the system
AU7453600A (en) Fishing game device
AU2001231447A1 (en) Artificial tree
AU2001259803A1 (en) Animal shelter
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2001278919A1 (en) Transgenic animal and methods
AU2001275736A1 (en) Improvements in animal cages
AU2001245574A1 (en) Fish bait device
AU5561301A (en) Transgenic animal
AU3616801A (en) Fishing sinker
AU2002230923A1 (en) Fish catching system
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2001270497A1 (en) Fishing bait
AUPQ574500A0 (en) Power hook, force flies and lures
AU2001274808A1 (en) Combined two-shoe tree and organizer
AU2001259670A1 (en) Animal harness
AU2002210769A1 (en) Bait device
AU2001284497A1 (en) Lure
AU2001244955A1 (en) Fishing tackle
AU2001271047A1 (en) P300 transgenic animal
AU2001244935A1 (en) Animal scarer
AU2001277716A1 (en) Transgenic animal
AU2000245353A1 (en) Fish-hook
AU6713100A (en) Animal model and uses thereof